OKX Europe’s pre-IPO contracts and tokenized stocks explained

What OKX is offering

OKX Europe’s product page offers Pre-IPO X-Perps referencing OpenAI and Anthropic alongside tokenized stocks. The pre-IPO contracts allow long or short exposure with leverage up to 10 times; tokenized stocks are backed by underlying shares. Neither gives the customer direct shareholder status or voting rights.

The distinction matters before thinking about price. Someone who wants to own company shares, someone who wants a share-backed token and someone who wants a leveraged contract are asking for different products. A familiar company name in a market listing does not make those products equivalent.

How the pre-IPO contract differs from equity

In its September 25 explainer, OKX describes Pre-IPO X-Perps as cash-settled derivatives whose price reflects trading supply and demand around an implied company valuation. They do not provide shares, voting rights or a claim on the company. OKX says the contract price can differ materially from a private funding-round valuation or an eventual IPO price.

The same explainer describes its tokenized stocks as one-for-one backed by shares held in custody. That is a different structure from the valuation-linked derivative. The product page also warns that an IPO may be delayed, cancelled or never happen, and that around-the-clock trading does not guarantee continuous liquidity or execution.

An example that separates exposure from ownership

Imagine three fictional records. The first says you hold ten company shares. The second says you hold ten tokens linked to shares. The third says you have a derivative position with a notional value of 1,000. Counting all three as “ten shares” would erase the information that defines what each record represents.

For a useful comparison, write down what the account actually holds, who issued the instrument, how its value is determined and what happens when it is closed or redeemed. Those questions are more informative than starting with the same company logo on three screens. They also make it easier to identify which terms you still need to read.

This example does not establish the legal rights of any particular instrument. Its purpose is to show why a label such as “company exposure” is only the beginning of an explanation. The product’s own documentation must supply the details that connect that label with the actual holding.

What leverage does to a simple price example

Consider an invented linear exposure of 1,000 supported by 100 of starting margin. A five-percent adverse move in that exposure corresponds to 50 before costs. Relative to the exposure, the change is five percent; relative to the starting margin, the same 50 is fifty percent. The two percentages use different denominators.

A five-percent favorable move would produce the opposite gross arithmetic in this simplified exercise. Neither case is a liquidation calculation or a forecast. It excludes funding, fees, changing margin requirements and differences in contract design. The example merely shows why a modest movement in the reference can be large compared with the money initially supporting a leveraged position.

It would also be incorrect to interpret the starting margin as the purchase price of company shares. In this example, 100 supports an exposure of 1,000; it does not prove that the customer bought equity worth 1,000 or acquired shareholder rights. Keep the instrument type beside every amount when comparing the alternatives.

What to check before treating the page as an opportunity

First decide which product you are actually researching. Then inspect its account-level eligibility, contract terms, price reference and applicable costs. If the purpose is IPO participation, establish whether the product offers an allocation process at all. A contract referencing a private company and an application for a new share offering should not be grouped together simply because both use the phrase “pre-IPO.”

The comparison below highlights those distinctions without opening a position. The discount offer elsewhere on this page is separate from the product structure: using a signup code does not turn a derivative into shares or establish eligibility. A clear decision starts with an accurate description of what would be held, followed by the specific terms shown to the eligible account.